Heparanase-1 and Cyclooxygenase-2: Prognostic indicators of malignancy in pheochromocytomas

Endocrine

Volumn 38, Issue 1, 2010, Pages 93-99

  Zhu, Yu ^a   He, Hong Chao ^a   Yuan, Fei ^a   Zhang, Jun ^a   Rui, Wen Bin ^a   Zhao, Ju Ping ^a   Shen, Zhou Jun ^a   Ning, Guang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cyclooxygenase 2; Heparanase 1; Immunohistochemistry; Microvessel density; Pheochromocytoma

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; CYCLOOXYGENASE 2; HEPARANASE;

ADOLESCENT; ADRENAL GLAND; ADRENALECTOMY; ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER RISK; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENZYME ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PHEOCHROMOCYTOMA; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK ASSESSMENT; SCHOOL CHILD;

EID: 77955323375     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-010-9356-y     Document Type: Article

References (25)

1. G Eisenhofer SR Bornstein FM Brouwers, et al. 2004 Malignant pheochromocytoma: current status, initiatives for future progress Endocr. Relat. Cancer 11 423 436 10.1677/erc.1.00829 1:CAS:528:DC%2BD2cXpsFCms78%3D 15369446 (Pubitemid 39331275)
2. RI Linnoila HR Keiser SM Steinberg EE Lack 1999 Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features Hum. Pathol. 21 1168 1180 10.1016/0046-8177(90)90155-X
3. E.E. Lack, Adrenal medullary hyperplasia and pheochromocytoma, in Pathology of the Adrenal Glands, ed. by E.E. Lack (Churchill Livingstone, New York, 1990), pp. 173-235
4. M Toyoshima M Nakajima 1999 Human heparanase: purification, characterization, cloning, expression J. Biol. Chem. 274 24153 24160 10.1074/jbc.274.34.24153 1:CAS:528:DyaK1MXlsVOntbg%3D 10446189 (Pubitemid 29390351)
5. RM Quiros AW Kim J Maxhimer P Gattuso X Xu RA Prinz 2002 Differential heparanase-1 expression in malignant, benign pheochromocytoma J. Surg. Res. 108 44 50 10.1006/jsre.2002.6451 1:CAS:528:DC%2BD38XosFOgt74%3D 12443714 (Pubitemid 35373814)
6. K Merati M said Siadaty A Andea, et al. 2001 Expression of inflammatory modulator CoX-2 in pancreatic ductal adenocarcinoma, its relationship to pathologic, clinical parameters Am. J. Clin. Oncol. 24 447 452 10.1097/00000421-200110000-00007 1:STN:280:DC%2BD3MrjvVKquw%3D%3D 11586094 (Pubitemid 32959100)
7. N Weidner 1995 Intratumor microvessel density as a prognostic factor in cancer Am. J. Pathol. 147 9 19 1:STN:280:DyaK2MzivVKhtA%3D%3D 7541613
8. HC Klingler PJ Klingler JK Martin Jr RC Smallridge SL Smith RA Hinder 2001 Pheochromocytoma Urology 57 1025 1032 10.1016/S0090-4295(01)00966-9 1:STN:280:DC%2BD387hslOnuw%3D%3D 11377298 (Pubitemid 32455560)
9. I Vlodavsky Y Friedmann M Elkin, et al. 1999 Mammalian heparanase: gene cloning, expression, function in tumor progression, metastasis Nat. Med. 5 793 802 10.1038/10518 1:CAS:528:DyaK1MXksVCrs7s%3D 10395325 (Pubitemid 29318614)
10. MD Hulett C Freeman BJ Hamdorf RT Baker MJ Harris CR Parish 1999 Cloning of mammalian heparanase, an important enzyme in tumor invasion, metastasis Nat. Med. 5 803 809 10.1038/10525 1:CAS:528:DyaK1MXksVCrs7g%3D 10395326 (Pubitemid 29318615)
11. A Koliopanos H Friess J Kleeff, et al. 2001 Heparanase expression in primary, metastatic pancreatic cancer Cancer Res. 61 4655 4659 1:CAS:528:DC%2BD3MXks1Grt7c%3D 11406531 (Pubitemid 32691870)
12. K Gohji H Hirano M Okamoto, et al. 2001 Expression of three extracellular matrix degradative enzymes in bladder cancer Int. J. Cancer 95 295 301 10.1002/1097-0215(20010920)95:5<295::AID-IJC1051>3.0.CO;2-A 1:CAS:528:DC%2BD3MXmslSlsLc%3D 11494228 (Pubitemid 32847039)
13. A Ferrandez S Prescott RW Burt 2003 CoX-2, colorectal cancer Curr. Pharm. Des. 9 2229 2251 10.2174/1381612033454036 1:CAS:528:DC%2BD3sXnsV2ms78%3D 14529404 (Pubitemid 37142440)
14. D Brattström K Wester M Bergqvist, et al. 2004 HER-2, EGFR, CoX-2 expression status correlated to microvessel density, survival in resected non-small cell lung cancer Acta Oncol. 43 80 86 10.1080/02841860310017441 15068324 (Pubitemid 38283177)
15. BS Sheu HB Yang SM Sheu AH Huang JJ Wu 2003 Higher gastric cycloxygenase-2 expression, precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients Clin. Cancer Res. 9 5245 5251 1:CAS:528:DC%2BD3sXovVOgu78%3D 14614005
16. GS Gupta M Srivastava N Ahmad DG Bostwick H Mukhtar 2001 Over expression of cyclooxygenase-2 in human prostate adenocarcinoma Prostate 42 73 78 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G
17. R Yoshimura H Sano M Mitsuhashi M Kohno J Chargui S Wada 2001 Expression of cyclooxygenase-2 in patients with bladder carcinoma J. Urol. 165 1468 1472 10.1016/S0022-5347(05)66329-X 1:CAS:528:DC%2BD3MXjvVaitb8%3D 11342898
18. R Yoshimura M Matsuyama Y Kawahito, et al. 2004 Study of cyclooxygenase-2 in renal cell carcinoma Int. J. Mol. Med. 13 229 233 1:CAS:528: DC%2BD2cXht1emu74%3D 14719128
19. K Saukkonen J Rintahaka A Sivula, et al. 2003 Cyclooxygenase-2, gastric carcinogenesis APMIS 111 915 925 10.1034/j.1600-0463.2003.1111001.x 1:CAS:528:DC%2BD3sXps12lsbw%3D 14616542 (Pubitemid 37352608)
20. K Salmenkivi C Haglund A Ristimäki J Arola P Heikkilä 2001 Increased expression of cyclooxygenase-2 in malignant pheochromocytomas J. Clin. Endocrinol. Metab. 86 5615 5619 10.1210/jc.86.11.5615 1:CAS:528: DC%2BD3MXos1Kqurk%3D 11701743 (Pubitemid 33070296)
21. JB Laforga FI Aranda 2000 Angiogenic index: a new method for assessing microvascularity in breast carcinoma with possible prognostic implications Breast J. 6 103 107 10.1046/j.1524-4741.2000.99011.x 11348344 (Pubitemid 30227088)
22. M Elkin N Ilan R Ishai-Michaeli, et al. 2001 Heparanase as mediator of angiogenesis: mode of action FASEB J. 15 1661 1663 1:CAS:528: DC%2BD3MXlvFejs7o%3D 11427519
23. T Imada J Matsuoka T Nobuhisa, et al. 2006 CoX-2 induction by heparanase in the progression of breast cancer Int. J. Mol. Med. 17 221 228 16391819
24. T Okawa Y Naomoto T Nobuhisa, et al. 2005 Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2 Clin. Cancer Res. 11 7995 8005 10.1158/1078-0432.CCR-05-1103 1:CAS:528: DC%2BD2MXht1entr7J 16299228 (Pubitemid 41698740)
25. Y Ohtawa Y Naomoto Y Shirakawa, et al. 2006 The close relationship between heparanase, cyclooxygenase-2 expressions in signet-ring cell carcinoma of the stomach Hum. Pathol. 37 1145 1152 10.1016/j.humpath.2006.04.005 1:CAS:528:DC%2BD28XovVWrtrY%3D 16938519 (Pubitemid 44286978)